MAIT cells are functionally impaired in a Mauritian cynomolgus macaque model of SIV and Mtb co-infection.
Animals
Coinfection
/ immunology
Granuloma
/ immunology
Lymph Nodes
/ immunology
Macaca fascicularis
Mucosal-Associated Invariant T Cells
/ immunology
Mycobacterium tuberculosis
/ immunology
Programmed Cell Death 1 Receptor
/ immunology
Receptors, Immunologic
/ immunology
Simian Acquired Immunodeficiency Syndrome
/ immunology
Simian Immunodeficiency Virus
/ immunology
Tuberculosis, Pulmonary
/ immunology
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
13
02
2020
accepted:
29
04
2020
revised:
02
06
2020
pubmed:
21
5
2020
medline:
22
7
2020
entrez:
21
5
2020
Statut:
epublish
Résumé
Mucosal-associated invariant T (MAIT) cells can recognize and respond to some bacterially infected cells. Several in vitro and in vivo models of Mycobacterium tuberculosis (Mtb) infection suggest that MAIT cells can contribute to control of Mtb, but these studies are often cross-sectional and use peripheral blood cells. Whether MAIT cells are recruited to Mtb-affected granulomas and lymph nodes (LNs) during early Mtb infection and what purpose they might serve there is less well understood. Furthermore, whether HIV/SIV infection impairs MAIT cell frequency or function at the sites of Mtb replication has not been determined. Using Mauritian cynomolgus macaques (MCM), we phenotyped MAIT cells in the peripheral blood and bronchoalveolar lavage (BAL) before and during infection with SIVmac239. To test the hypothesis that SIV co-infection impairs MAIT cell frequency and function within granulomas, SIV+ and -naïve MCM were infected with a low dose of Mtb Erdman, and necropsied at 6 weeks post Mtb-challenge. MAIT cell frequency and function were examined within the peripheral blood, BAL, and Mtb-affected lymph nodes (LN) and granulomas. MAIT cells did not express markers indicative of T cell activation in response to Mtb in vivo within granulomas in animals infected with Mtb alone. SIV and Mtb co-infection led to increased expression of the activation/exhaustion markers PD-1 and TIGIT, and decreased ability to secrete TNFα when compared to SIV-naïve MCM. Our study provides evidence that SIV infection does not prohibit the recruitment of MAIT cells to sites of Mtb infection, but does functionally impair those MAIT cells. Their impaired function could have impacts, either direct or indirect, on the long-term containment of TB disease.
Identifiants
pubmed: 32433713
doi: 10.1371/journal.ppat.1008585
pii: PPATHOGENS-D-20-00276
pmc: PMC7266356
doi:
Substances chimiques
Pdcd1 protein, mouse
0
Programmed Cell Death 1 Receptor
0
Receptors, Immunologic
0
T cell Ig and ITIM domain protein, mouse
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008585Subventions
Organisme : NIH HHS
ID : P51 OD011106
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111815
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI127127
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Immunol. 2007 Nov 15;179(10):6973-80
pubmed: 17982088
PLoS One. 2012;7(3):e34156
pubmed: 22479548
J Virol. 2018 Jan 17;92(3):
pubmed: 29118125
Front Immunol. 2020 Jan 17;10:3053
pubmed: 32010135
Sci Transl Med. 2010 Mar 10;2(22):22ra18
pubmed: 20375000
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Nat Commun. 2016 Jun 23;7:11653
pubmed: 27337592
Cell Rep. 2019 Feb 5;26(6):1409-1418.e5
pubmed: 30726727
J Clin Invest. 2020 Jan 2;130(1):214-230
pubmed: 31763997
J Immunol. 2019 Apr 1;202(7):2105-2120
pubmed: 30777923
Infect Immun. 2018 Nov 20;86(12):
pubmed: 30201702
J Immunol. 2019 Dec 1;203(11):2917-2927
pubmed: 31611259
Cytokine. 2013 Jul;63(1):43-51
pubmed: 23643185
Immunity. 1995 Jun;2(6):561-72
pubmed: 7540941
Nat Immunol. 2010 Aug;11(8):701-8
pubmed: 20581831
Immunol Cell Biol. 2018 Jul;96(6):630-641
pubmed: 29350807
PLoS Pathog. 2011 Aug;7(8):e1002055
pubmed: 21852945
Infect Immun. 2012 Sep;80(9):3256-67
pubmed: 22778103
Immunol Rev. 2015 Mar;264(1):154-66
pubmed: 25703558
Infect Immun. 2001 Mar;69(3):1847-55
pubmed: 11179363
J Immunol. 2009 Feb 15;182(4):1794-8
pubmed: 19201830
Arch Bronconeumol. 2020 Jul;56(7):446-454
pubmed: 35373756
J Virol. 2013 Aug;87(16):9353-64
pubmed: 23785211
Cell Rep. 2017 Mar 28;18(13):3091-3104
pubmed: 28355562
Clin Exp Immunol. 2010 Jul 1;161(1):1-9
pubmed: 20491796
J Virol. 2009 Nov;83(22):11514-27
pubmed: 19726517
PLoS Pathog. 2016 Mar 31;12(3):e1005524
pubmed: 27031111
J Clin Invest. 2019 Dec 2;129(12):5254-5260
pubmed: 31479428
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5434-E5443
pubmed: 28630305
Virology. 2002 Nov 25;303(2):327-37
pubmed: 12490394
Infect Immun. 2018 Nov 20;86(12):
pubmed: 30224552
J Exp Med. 1999 Jun 21;189(12):1907-21
pubmed: 10377186
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3006-11
pubmed: 20133607
PLoS Biol. 2009 Mar 10;7(3):e54
pubmed: 19278296
Blood. 2013 Feb 14;121(7):1124-35
pubmed: 23243281
PLoS One. 2015 May 01;10(5):e0125500
pubmed: 25933119
J Leukoc Biol. 2016 Jul;100(1):233-40
pubmed: 27034405
Sci Immunol. 2018 Jul 13;3(25):
pubmed: 30006464
Blood. 2013 Feb 7;121(6):951-61
pubmed: 23255555
Cytokine Growth Factor Rev. 2013 Apr;24(2):105-13
pubmed: 23168132
J Virol. 2016 Oct 28;90(22):10339-10350
pubmed: 27630228
Mucosal Immunol. 2017 May;10(3):802-813
pubmed: 27759023
J Immunol. 2015 Jul 15;195(2):587-601
pubmed: 26063000
J Leukoc Biol. 2017 Nov;102(5):1261-1269
pubmed: 28807929
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5636-44
pubmed: 27601645
AIDS. 2018 Oct 23;32(16):2279-2289
pubmed: 30102653
Blood. 2013 Jan 24;121(4):614-23
pubmed: 23223428
Immunogenetics. 2019 Feb;71(2):109-121
pubmed: 30353260
Infect Immun. 2018 Jan 22;86(2):
pubmed: 28947646
Cell Rep. 2019 Sep 17;28(12):3061-3076.e5
pubmed: 31533031
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Nature. 2003 Mar 13;422(6928):164-9
pubmed: 12634786
N Engl J Med. 2001 Oct 11;345(15):1098-104
pubmed: 11596589
Immunogenetics. 2010 Dec;62(11-12):773-80
pubmed: 20882385
PLoS One. 2015 Apr 20;10(4):e0124659
pubmed: 25894562
Arthritis Rheum. 2010 Feb;62(2):340-50
pubmed: 20112395
Commun Biol. 2019 Jun 5;2:203
pubmed: 31231693
Nat Commun. 2020 Jan 14;11(1):272
pubmed: 31937782
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11513-E11522
pubmed: 30442667
PLoS Biol. 2010 Jun 29;8(6):e1000407
pubmed: 20613858
Infect Immun. 2017 Mar 23;85(4):
pubmed: 28115506
Cell Rep. 2019 Sep 17;28(12):3077-3091.e5
pubmed: 31533032
J Virol. 2016 Apr 14;90(9):4520-4529
pubmed: 26912615
Mucosal Immunol. 2008 Jan;1(1):49-58
pubmed: 19079160
Tuberculosis (Edinb). 2015 May;95(3):267-74
pubmed: 25837440
Front Immunol. 2014 Oct 08;5:450
pubmed: 25339949
J Exp Med. 2014 Jul 28;211(8):1601-10
pubmed: 25049333
PLoS One. 2013 Dec 31;8(12):e83474
pubmed: 24391773
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Annu Rev Immunol. 2018 Apr 26;36:603-638
pubmed: 29490165
J Exp Med. 2000 Aug 7;192(3):347-58
pubmed: 10934223
Am J Respir Crit Care Med. 2015 Feb 15;191(4):464-73
pubmed: 25536276
J Leukoc Biol. 2016 Aug;100(2):305-14
pubmed: 27256572
Blood. 2011 Jan 27;117(4):1250-9
pubmed: 21084709